Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FD4XJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $16,249.95, awards pharmaceutical supplies to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for Stelara 90 mg/ml syringes and was issued by the Defense Logistics Agency (DLA) under a firm fixed-price contract structure with an ultimate completion date of September 19, 2025. No set-aside designation was used for this award, allowing the vendor to compete on an unrestricted basis. Stelara is a biologic medication used to treat various autoimmune conditions, and this delivery supports the pharmaceutical supply needs of military healthcare facilities.
This delivery order derives from DMS Pharmaceutical Group's significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to consistently secure contracts that support Department of Defense healthcare sites worldwide.
Quick answers
Who was awarded contract SPE2DB25FD4XJ?
SPE2DB25FD4XJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FD4XJ worth?
The government has obligated $16,250 on SPE2DB25FD4XJ.
Is contract SPE2DB25FD4XJ an order under another contract?
Yes. SPE2DB25FD4XJ is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB25FD4XJ competed?
The extent of competition for SPE2DB25FD4XJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award